X-PSOLVE+ Scan: New articles on severe psoriasis September 12, 2021
Clin Exp Dermatol. 2021 Sep 12. doi: 10.1111/ced.14933. Online ahead of print.Nail psoriasis (NP) remains a challenging clinical problem. Our previous case report showed that intramatricial low-dose secukinumab (an anti-IL-17A monoclonal antibody) injection could improve the condition of NP significantly.1 But the efficacy difference between nail matrix (pitting, leukonychia, nail plate crumbling and red lunula) and nail bed (oil-dropping sign, onycholysis, subungual hyperkeratosis and splinter hemorrhages) was unclear.PMID:34510518 | DOI:10.1111/ced.14933
Full text access may require purchase from the publisher, or a login through your institution's library or computer network.